Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Bellerophon Therapeutics, Inc. (BLPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Amin Naseem (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 47,578 shares
@ $0 |
|
| 06/09/2023 |
4
| Fernandes Peter (See Remarks) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.8264, valued at
$82.6k
|
|
| 06/09/2023 |
4
| Shah Parag Suresh (VP of Business Operations) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.8264, valued at
$41.3k
|
|
| 06/09/2023 |
4
| Dekker Martin (See Remarks) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.8264, valued at
$41.3k
|
|
| 06/09/2023 |
4
| Bruder Scott P (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 06/09/2023 |
4
| Kim Bobae (VP Reg. Affairs & Quality) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.8264, valued at
$41.3k
|
|
| 06/09/2023 |
4
| Wang Theodore T (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 06/09/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 06/09/2023 |
4
| Teufel Crispin (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 14,607 options to buy
@ $0.8264, valued at
$12.1k
|
|
| 06/07/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 134,421 shares
@ $0.83, valued at
$111.6k
|
|
| 05/22/2023 |
4
| Kim Bobae (VP Reg. Affairs & Quality) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 9,455 shares
@ $10, valued at
$94.6k
Exercised 266 options to buy
@ $7.35, valued at
$2k
Exercised 1,022 options to buy
@ $7.5, valued at
$7.7k
|
|
| 05/19/2023 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Sold 560,000 shares
@ $9.46, valued at
$5.3M
|
|
| 02/14/2023 |
4
| Amin Naseem (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 84,000 shares
@ $0 |
|
| 02/14/2023 |
4
| Teufel Crispin (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $1.52, valued at
$44.1k
|
|
| 02/14/2023 |
4
| Dekker Martin (VP OF ENGINEERING & MANUFACTUR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.52, valued at
$76k
|
|
| 02/14/2023 |
4
| Shah Parag Suresh (VP OF BUSINESS OPERATIONS) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.52, valued at
$76k
|
|
| 02/14/2023 |
4
| Fernandes Peter (CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.52, valued at
$152k
|
|
| 02/14/2023 |
4
| Laccona Nicholas (FINANCIAL OFFICER, (PFO & PAO)) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.52, valued at
$76k
|
|
| 02/14/2023 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $1.52, valued at
$44.1k
|
|
| 02/14/2023 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 29,000 options to buy
@ $1.52, valued at
$44.1k
|
|
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| Fernandes Peter (CHIEF REGULATORY & SAFETY OFFR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 65,000 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Dekker Martin (VP OF ENGINEERING & MANUFACTUR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 51,000 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Shah Parag Suresh (VP OF BUSINESS OPERATIONS) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 51,000 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Laccona Nicholas (FINANCIAL OFFICER, (PFO & PAO)) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 36,000 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Cloyd Mary Ann (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 01/04/2022 |
4
| Wang Theodore T (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 01/04/2022 |
4
| Teufel Crispin (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 01/04/2022 |
4
| Bruder Scott P (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 21,828 options to buy
@ $3.1, valued at
$67.7k
|
|
| 01/04/2022 |
4
| Amin Naseem (Director) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 39,032 shares
@ $0
Granted 8,671 options to buy
@ $3.1, valued at
$26.9k
|
|
| 06/08/2021 |
4
| Puissance Life Science Opportunities Fund VI (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 8,189 shares
@ $4, valued at
$32.8k
|
|
|
|
|